New STELARA® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis ...Middle East

Final cumulative pooled IBD safety data support the longstanding safety profile of STELARA across all IBD approved indications Additional long term extension data demonstrate more than half of STELARA-treated patients with ulcerative colitis achieved clinical remission, clinical response,...

Hence then, the article about new stelara ustekinumab long term data support its established safety profile in inflammatory bowel disease and durable efficacy in ulcerative colitis was published today ( Saturday 04/03/2023 - 02:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New STELARA® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis )

Also on site :

• Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal
• Mira Murati’s startup, Thinking Machines Lab, is losing two of its co-founders to OpenAI
• ‘I hope they show humanity’: Greenlanders fear Trump’s desire for minerals